Day: August 23, 2024

JACKSONVILLE, Fla., Aug. 23, 2024 (GLOBE NEWSWIRE) — CSX (NASDAQ: CSX) today announced that it has reached new tentative five-year collective bargaining agreements with seven additional labor unions. These agreements cover the following groups:The Brotherhood of Maintenance of Way Employes Division of the International Brotherhood of Teamsters (BMWED), covering maintenance of way employees; The International Association of Machinists & Aerospace Workers (IAM) covering machinists and roadway mechanics. The International Association of Sheet Metal, Air, Rail and Transportation Workers – Transportation Division (SMART-TD), covering the yardmasters; The Brotherhood of Railway Carmen (BRC) covering carmen at the Fruit Growers Express Company subsidiary of CSX; The Transportation Communications Union (TCU) covering the clerical...

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES OF AMERICA CALGARY, Alberta, Aug. 23, 2024 (GLOBE NEWSWIRE) — Canadian Premium Sand Inc. (“CPS” or the “Company”) (TSXV: CPS) is pleased to announce that it intends to extend the expiry date of an aggregate of 26,494,908 warrants (the “Warrants“) to purchase an aggregate of 26,494,908 common shares (“Common Shares“) of the Company. The Warrants were issued pursuant to a private placement unit offering that closed August 31, 2022 and are currently set to expire on August 31, 2024. The Company intends to extend the expiry date by 4 months to December 31, 2024. All other terms of the Warrants, including the exercise price of $0.40 per Common Share, will remain unchanged.  In the event that the 30-day volume weighted average...

CALGARY, ALBERTA, Aug. 23, 2024 (GLOBE NEWSWIRE) — Marksmen Energy Inc. (“Marksmen” or the “Company”) announces that it has completed the closing of its previously announced non-brokered private placement of units (the “Units”) of Marksmen (the “Offering”). The Company issued 19,325,000 Units at a price of $0.01 per Unit for aggregate gross proceeds of $193,250. Each Unit is comprised of one (1) common share (“Common Share”) and one (1) share purchase warrant (“Warrant”) of Marksmen. Each whole Warrant entitles the holder thereof to purchase one Common Share at a price of $0.05 per share expiring two (2) years from the date of issuance, subject to acceleration provisions (see news release dated May 10, 2024). Marksmen paid no cash commissions pursuant to the Offering and intends to use the gross proceeds of $193,250 in the following...

INCLINE VILLAGE, Nev., Aug. 23, 2024 (GLOBE NEWSWIRE) — On Thursday evening, a lucky guest from San Francisco won $1,137,093.42 at Grand Lodge Casino, located in Incline Village, Nevada, near Lake Tahoe. The lucky winner was betting $10 on the Five Times Pay version of Wheel of Fortune Gold Spin Deluxe. “With this latest jackpot, the casino has paid out almost $9 million in Wheel of Fortune Wide Area Progressives,” said Grand Lodge Casino Director of Marketing, Jill Stewart. “To have so many life-changing jackpots here is incredible. We pride ourselves on our customer service and the beautiful atmosphere. Hopefully this shows people you can win just as much at Grand Lodge Casino as you can at the big resorts.” Grand Lodge Casino has been an institution in Incline Village for many years. The casino recently signed a 10-year lease...

SAN DIEGO, Aug. 23, 2024 (GLOBE NEWSWIRE) — Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biopharmaceutical company focused on unlocking new therapeutic pathways for metabolic health, today announced that on August 22, 2024, the Board of Directors granted a non-qualified stock option award to purchase 40,000 shares of its common stock to one new non-executive employee under the Company’s 2024 Inducement Equity Incentive Plan (the “2024 Inducement Plan”). The stock options were granted as an inducement material to the employee entering into employment with Skye in accordance with Nasdaq Listing Rule 5635(c)(4). The 2024 Inducement Plan is used exclusively for the grant of equity awards to individuals who were not previously employees of Skye, or following a bona fide period of non-employment, as an inducement material...

Millicom announces expiration of consent solicitations Luxembourg, August 23, 2024 – Millicom International Cellular S.A. (“Millicom”) today announced the expiration of its previously announced solicitation of consents from the holders of record on August 2, 2024 of its 6.625% Senior Notes due 2026, 5.125% Senior Notes due 2028, 6.250% Senior Notes due 2029, 4.500% Senior Notes due 2031 and 7.375% Senior Notes due 2032 (collectively, the “Notes”) to amend certain provisions of the indentures governing the Notes (the “Proposed Amendments”), and that the Proposed Amendments will not be made. This announcement does not constitute an offer to sell or issue, or the solicitation of an offer to buy or subscribe for, securities (including the Notes) in any jurisdiction. -END- For further information, please contactPress: Sofía Corral, Director...

BOCA RATON, Fla., Aug. 23, 2024 (GLOBE NEWSWIRE) — Entero Therapeutics, Inc., (NASDAQ: ENTO), (“Entero Therapeutics” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, today announced that it received a letter from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) advising that, because the Company failed to timely file its Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2024 (the “Form 10-Q”), the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Rule”). Nasdaq has informed the Company that it has until October 21, 2024, to submit a plan to regain compliance with the Rule. If Nasdaq approves the Company’s plan, it has the discretion to grant the Company...

FLORHAM PARK, N.J., Aug. 23, 2024 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of drugs for the treatment of cancer, today announced that the Company had received an expected delinquency notification letter (the “Notice”) from the Listing Qualifications Staff of the Nasdaq Stock Market LLC (“Nasdaq”) on August 20, 2024. The Notice indicated that the Company is not in compliance with the periodic financial report filing requirement set forth in Nasdaq Listing Rule 5250(c)(1) as a result of the Company’s delay in filing its Quarterly Report on Form 10-Q for the quarter ended June 30, 2024 (the “Second Quarter 10-Q”), by the applicable due date. The delay in filing the Second Quarter 10-Q is a result...

FRANKLIN, TN, Aug. 23, 2024 (GLOBE NEWSWIRE) — IMAC Holdings, Inc. (“IMAC” or the “Company”) (NASDAQ: BACK) today announced that it received an expected deficiency notification letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”) on August 21, 2024 (the “Notice”). The Notice indicated that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”) as a result of its failure to timely file its Quarterly Report on Form 10-Q for the period ended June 30, 2024 (the “Form 10-Q”), as described more fully in the Company’s Form 12b-25 Notification of Late Filing (the “Form 12b-25”) filed with the Securities and Exchange Commission (the “SEC”) on August 15, 2024. The Listing Rule requires Nasdaq-listed companies to timely file all required periodic reports with the...